课题基金 / 基金详情

项目摘要

项目成果

GIL ALTEROVITZ的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Today, ontologies are critical instruments for biomedical investigators, especially in those areas, such as cancer research, that require the command of a vast amount of information and a systemic approach to the design and interpretation of experiments. In fact, ontologies are proliferating in all areas of biomedical research, offering both challenges and opportunities. One of the principal challenges of this field stems from the fact that ontologies are developed in isolation, rendering it impossible to move, for instance, from genes to organisms, to diseases, to drugs. The National Center for Biomedical Ontology (NCBO) represents a fundamental endeavor in the collection, coordination and distribution of biomedical ontologies and offers an unparalleled opportunity to combine these biomedical ontologies into a single search space where genetic, anatomic, molecular and pharmacological information can be seamlessly explored and exploited as a holistic representation of biomedical knowledge. Unfortunately, ontology integration using standard means of manual curation is a labor intensive task, unable to scale up and keep up with the current growth rate of biomedical ontologies. We have developed a systematic framework for automated ontology engineering based on information theory, and we have successfully applied it to the analysis and engineering of Gene Ontology (GO), the development gene and protein databases, and the identification of peripheral biomarkers of disease progression and drug response. This project brings together a unique group of competences, ranging from ontology engineering, statistical signal processing, bioinformatics, cancer research, and clinical pharmacogenomics, to develop a principled method, grounded on the mathematics of information theory, to automatically combine and integrate biomedical ontologies and implement it as part of the NCBO architecture
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Towards a generalizable drug discovery framework based on intrinsically disordered regions
  • 批准号:
    10116778
  • 项目类别:
  • 资助金额:
    $36.99万
  • 财政年份:
    2016
  • 负责人:
    GIL ALTEROVITZ
  • 依托单位:
NOT-GM-21-028:Towards a generalizable drug discovery framework based on intrinsically disordered regions
  • 批准号:
    10393070
  • 项目类别:
  • 资助金额:
    $1.43万
  • 财政年份:
    2016
  • 负责人:
    GIL ALTEROVITZ
  • 依托单位:
A Holistic Approach to Information Processing for Biomedical Networks
  • 批准号:
    8324015
  • 项目类别:
  • 资助金额:
    $23.89万
  • 财政年份:
    2008
  • 负责人:
    GIL ALTEROVITZ
  • 依托单位:
A Holistic Approach to Information Processing for Biomedical Networks
  • 批准号:
    8123728
  • 项目类别:
  • 资助金额:
    $24.9万
  • 财政年份:
    2008
  • 负责人:
    GIL ALTEROVITZ
  • 依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
  • 批准号:
    2021JJ40433
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2021
  • 负责人:
    孙磊
  • 依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
  • 批准号:
    32001603
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    段真珍
  • 依托单位:
AREA国际经济模型的移植.改进和应用
  • 批准号:
    18870435
  • 项目类别:
    面上项目
  • 资助金额:
    2.0万元
  • 批准年份:
    1988
  • 负责人:
    史树中
  • 依托单位: